Mark Yarchoan MDAssociate Professor of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland
Mark Yarchoan, MD, is an Associate Professor of Medical Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore Maryland. Dr. Yarchoan runs an NCI-funded laboratory focused on developing novel immunotherapies for hepatobiliary cancers. He also leads multiple clinical trials of immunotherapy agents for hepatobiliary cancers.
Dr. Yarchoan reports research grants (to Johns Hopkins) from Genentech, Bristol-Myers Squibb, and Incyte and consulting fees from Genentech, Exelixis, Eisai, AstraZeneca, Replimune, Hepion, and Lantheus.